Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The introduction and approval of new and innovative growth hormone (GH) products are significantly driving the growth of the growth hormone market. These novel products offer several advantages over traditional GH treatments, making them more appealing to patients and healthcare providers.
Key Factors Driving Growth Hormone Market Growth:
Convenient and Safe Treatment Options: Newer GH products are designed for once-weekly or less frequent administration, reducing the burden of daily injections and improving patient compliance. Additionally, these products are associated with a lower risk of injection-site reactions, enhancing patient comfort and safety.
Gene Editing Technology for Improved Efficacy and Safety: The use of gene editing technology in the development of GH products is leading to more effective and safer treatments. This technology allows for precise modifications to the genetic code, resulting in GH products with enhanced efficacy and reduced side effects.
Product Launch and Approval Highlights:
June 2023: Pfizer and OPKO Health received US FDA approval for Ngenla (somatrogon-ghla) for growth failure treatment. This product offers once-weekly dosing and has been approved in over 40 markets worldwide.
January 2022: TransCon hGH, developed by Ascendis Pharma, received European Commission approval for pediatric growth. This once-weekly injectable product is a prodrug of somatropin, providing sustained release of unmodified somatropin (hGH).
August 2020: The US FDA granted approval for Sogroya (somapacitan) from Novo Nordisk. This once-weekly injectable product is designed for the treatment of growth hormone deficiency in adults, offering a more convenient alternative to daily injections.
These product launches and approvals exemplify the ongoing efforts to develop GH products that are more convenient, safer, and effective, further fueling the growth of the growth hormone market.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Brand, Route of Administration, Application, Distribution Channel, and Region |
Human Growth Hormone Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
